追踪和阿尔茨海默病之间的路径 - - 一篇文献评论

相关实验视频

Updated: Jul 20, 2025

10:52

Correlative Light and Electron Microscopy to Study Microglial Interactions with β-Amyloid Plaques

Published on: June 1, 2016

11.5K

Ana Margarida Silva¹, Marco Preto², Clara Grosso³

¹Ciências Químicas e das Biomoléculas, Escola Superior de Saúde, Instituto Politécnico do Porto, 4200-072 Porto, Portugal.

Molecules (Basel, Switzerland)

|July 29, 2023

概括

对阿尔茨海默氏病 (AD) 治疗具有前景,因为它准了像粉样蛋白β和蛋白这样的关键机制. 这篇评论汇编了化合物.

科学领域:

神经科学是一个神经科学.
药理学药理学是指药理学的学科.
自然产品化学自然产品化学

背景情况:

阿尔茨海默病 (AD) 是一种流行的神经退行性疾病,导致认知能力下降和痴呆,有效治疗方法有限.
目前的阿尔茨海默病疗法主要是治疗症状,这凸显了针对疾病进展的新型治疗策略的需要.
自然化合物,特别是来自的化合物,越来越多地被研究其潜在的药用益处,包括神经保护.

研究的目的:

审查和综合现有的关于衍生物化合物对阿尔茨海默病 (AD) 的治疗潜力的文献.
探索各种提取物和分离化合物如何向特定的AD相关机制.
巩固证据支持作为新型AD治疗的来源.

主要方法:

在文献中搜索和审查研究提取物和化合物对抗AD病理的研究.
对对乙胆化酶 (AChE) 和β-分泌酶 (BACE 1) 抑制作用的研究分析.
关于衍生物化合物的抗氧化,抗炎和抗氨基原性质的数据汇编,与AD相关.

主要成果:

来自的天然产品在抑制关键酶如ACHE和BACE1方面具有显著的潜力,这些酶在AD病变发生过程中至关重要.
来自各种的化合物通过防止粉样β (Aβ) 聚合和相关的神经毒性来表现出神经保护作用.
有证据表明,具有抗氧化和抗炎性质,可以减轻AD相关的细胞损伤和炎症.
化合物还显示出防止蛋白表达和聚合的潜力,这是AD的另一个标志.

结论:

提取物和分离化合物代表了开发针对阿尔茨海默病的新治疗策略的有希望的途径.
多方面的作用机制,包括酶抑制和抗聚合效应,强调了在阿尔茨海默病中的治疗潜力.
对特定化合物的进一步研究可能会导致针对阿尔茨海默病的潜在病理,而不仅仅是症状的新型治疗方法.

关键词:

阿尔茨海默氏症是阿尔茨海默氏症的一种疾病.这些都是,,.自然产品是自然产品的产品.治疗疗法治疗疗法治疗疗法

相关概念视频

01:26

Alzheimer's Disease: Overview

522

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...

522

01:22

Alzheimer's Disease: Treatment

218

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...

218

01:23

Role of Neurotransmitters in Memory

630

Neurotransmitters are integral to the brain's communication system, enabling neurons to transmit signals across synapses. This chemical exchange underpins various cognitive functions, including memory processes. The role of neurotransmitters in memory is multifaceted, influencing the encoding, consolidation, and retrieval of memories through their action on different neural circuits.
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...

630

03:03

Amyloid Fibrils

9.6K

Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...

9.6K

01:30

Dementia

139

Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....

139